Dermatology

Your Article Summary

See Latest Articles

Rapamycin selectively inhibits expression of an inducible keratin (K6a) in human keratinocytes and improves symptoms in pachyonychia congenita patients
Journal of Dermatological Science, 10/06/09

Hickerson RP et al. – Rapamycin selectively blocks K6a expression in human keratinocytes. The improvement of symptoms in PC patients following rapamycin treatment suggests rapamycin (or rapamycin analogs) may be a therapeutic option, particularly if topical formulations can be developed that avoid the side effects associated with systemic administration.

Today in Basic Science/Genetics...keeping you current

Receive free subspecialty "5-minute updates" via email

Usefulness of the CD63 basophil activation test in detecting Anisakis hypersensitivity in patients with chronic urticaria: diagnosis and follow-up
Clinical and Experimental Dermatology, 11/02/09

C-Kit (CD117) expression in classic Kaposis sarcoma
Clinical and Experimental Dermatology, 11/02/09

ADAM10 Is Upregulated in Melanoma Metastasis Compared with Primary Melanoma
Journal of Investigative Dermatology, 11/03/09

See All of Basic Science/Genetics

Today in Clinical Pharmacology...keeping you current

Receive free subspecialty "5-minute updates" via email

Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09

Topical Pimecrolimus: A Review of its Use in the Management of Pediatric Atopic Dermatitis
Pediatric Drugs, 11/06/09

Clinical Importance of Purulence in Methicillin-Resistant Staphylococcus aureus Skin and Soft Tissue Infections
Journal of the American Board of Family Medicine, 11/09/09

See All of Clinical Pharmacology

Today in Dermatopathology...keeping you current

Receive free subspecialty "5-minute updates" via email

Erysipeloid: a review
Clinical and Experimental Dermatology, 09/18/09

Update on oral lichen planus
Expert Review of Dermatology, 10/14/09

Childhood melanoma
Clinics in Dermatology, 11/04/09

See All of Dermatopathology